Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
20 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/20/3084703/0/en/Pasithea-Therapeutics-Announces-Preclinical-Data-that-Shows-PAS-004-Inhibits-ETS2-Signaling-a-Key-Driver-of-Inflammation-in-IBD-and-Other-Large-Addressable-Market-Diseases.html
14 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/14/3081003/0/en/Pasithea-Therapeutics-Announces-Initiation-of-Phase-1-1B-Study-of-PAS-004-in-Adult-NF1-Patients-and-Activation-of-First-Clinical-Trial-Site.html
07 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/07/3076679/0/en/Pasithea-Therapeutics-Announces-Closing-of-5-Million-Public-Offering.html
06 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/06/3074902/0/en/Pasithea-Therapeutics-Reports-Positive-Pharmacodynamic-Results-Demonstrating-Robust-Target-Engagement-from-its-Ongoing-Phase-1-Clinical-Trial-of-PAS-004.html
06 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/06/3075278/0/en/Pasithea-Therapeutics-Announces-Pricing-of-5-Million-Public-Offering.html
29 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/29/3070044/0/en/Pasithea-Therapeutics-Announces-Completion-of-Enrollment-and-Initial-Dosing-of-Patients-in-Cohort-6-from-its-Phase-1-Trial-of-PAS-004-in-Advanced-Cancer-Patients.html
ABOUT THIS PAGE